Hang Sheng Zhou
Chief Executive Officer en Wuhan Dangdai Science & Technology Industry (Group) Co., Ltd. .
Perfil
Hang Sheng Zhou is currently the Chief Executive Officer at Wuhan Dangdai Science & Technology Industry (Group) Co., Ltd.
Prior to this, he worked as the Chief Financial Officer & Managing Director at Humanwell Healthcare (Group) Co., Ltd.
Dr. Zhou also served as an Independent Non-Executive Director at AbelZeta Pharma, Inc. from 2016 to 2021.
He received his undergraduate degree from Wuhan University and his doctorate from Beijing Institute of Technology.
Cargos activos de Hang Sheng Zhou
| Empresas | Cargo | Inicio |
|---|---|---|
Wuhan Dangdai Science & Technology Industry (Group) Co., Ltd.
 Wuhan Dangdai Science & Technology Industry (Group) Co., Ltd. Financial ConglomeratesFinance Part of Wuhan Dangdai Technology Industry Group Co. Ltd., Wuhan Dangdai Science & Technology Industry (Group) Co., Ltd. operates as an investment holding private company. The company is based in Wuhan, China. The CEO of the Chinese company is Hang Sheng Zhou. | Chief Executive Officer | - |
Antiguos cargos conocidos de Hang Sheng Zhou.
| Empresas | Cargo | Fin |
|---|---|---|
| CELLULAR BIOMEDICINE GROUP, INC. | Director/Board Member | 19/02/2021 |
| HUMANWELL HEALTHCARE (GROUP) CO.,LTD. | Chief Executive Officer | - |
Formación de Hang Sheng Zhou.
| Wuhan University | Undergraduate Degree |
| Beijing Institute of Technology | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| HUMANWELL HEALTHCARE (GROUP) CO.,LTD. | Health Technology |
| Empresas privadas | 2 |
|---|---|
AbelZeta Pharma, Inc.
 AbelZeta Pharma, Inc. BiotechnologyHealth Technology Cellular Biomedicine Group, Inc. is a holding company, which engages in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell-based technologies. It specializes in immune cell therapy. The company was founded in 2009 and is headquartered in Rockville, MD. | Health Technology |
Wuhan Dangdai Science & Technology Industry (Group) Co., Ltd.
Wuhan Dangdai Science & Technology Industry (Group) Co., Ltd. Financial ConglomeratesFinance Part of Wuhan Dangdai Technology Industry Group Co. Ltd., Wuhan Dangdai Science & Technology Industry (Group) Co., Ltd. operates as an investment holding private company. The company is based in Wuhan, China. The CEO of the Chinese company is Hang Sheng Zhou. | Finance |
- Bolsa de valores
- Insiders
- Hang Sheng Zhou
